Last reviewed · How we verify

Gan Fu Le Tablets — Competitive Intelligence Brief

Gan Fu Le Tablets (Gan Fu Le Tablets) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Hepatology.

phase 3 Hepatology Small molecule Live · refreshed every 30 min

Target snapshot

Gan Fu Le Tablets (Gan Fu Le Tablets) — Shenzhen Kangzhe Pharmaceutical Co., Ltd.. Gan Fu Le Tablets is a traditional Chinese medicine formulation designed to support liver function and promote hepatic health.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Gan Fu Le Tablets TARGET Gan Fu Le Tablets Shenzhen Kangzhe Pharmaceutical Co., Ltd. phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Gan Fu Le Tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/gan-fu-le-tablets. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing